HER-2/neu biomarker expression in pre cancerous and cancerous lesions of uterus cervix
Not Applicable
- Conditions
- Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
- Registration Number
- CTRI/2022/11/047316
- Lead Sponsor
- Rohilkhand Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All histologically diagnosed cases of premalignant and malignant epithelial lesions of cervix received in Department of Pathology in Rohilkhand Medical College and Hospital during study period.
Exclusion Criteria
All histologically proven cases of inflammatory, benign lesions and stromal tumors of uterine cervix; inadequate biopsy specimen; patients already on treatment.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Immunohistochemical expression of HER-2/neu in premalignant and malignant epithelial lesions of uterine cervix.Timepoint: Baseline investigation
- Secondary Outcome Measures
Name Time Method ilTimepoint: Nil